Why the study?
Does exclusion of the left atrial appendage prevent systemic embolism in patients with atrial fibrillation?
Does exclusion of the left atrial appendage prevent systemic embolism in patients with atrial fibrillation?
Left atrial appendage exclusion shows potential for preventing systemic embolism in atrial fibrillation but is not yet a standard alternative to oral anticoagulation.
LAA exclusion not supported as anticoagulation alternative in AF; leaves open its role pending randomized trials.
Left atrial appendage is the most frequent place of blood clot formation in heart cavities. The thrombus formation increases a risk of a systemic embolism especially in patients with a permanent atrial fibrillation. The standard preventive treatment is the oral anticoagulation therapy. Another possible treatment is an exclusion of a left atrial appendage. We present current overview of risks and benefits of surgical and percutaneous elimination of a left atrial appendage. We present the first experience with AMPLATZER Cardiac Plug system in an elimination of a left atrial appendage. We concluded that an exclusion of left atrial appendage could become a useful possibility of prevention of systemic embolization in patients with an atrial fibrillation, but is not still an alternative therapy for anticoagulation therapy at present.
No takes yet. Share an insight, caveat, or question.
Šťásek et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: